Science

2021

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

Waqas K, Lima Ferreira J, Tsourdi E, Body JJ, Hadji P, Zillikens MC

Journal: Journal of Bone Oncology
Volume: 28
Année: Mars 2021
Pages: Article 100355

https://doi.org/10.1016/j.jbo.2021.100355

Antiproliferative Properties of Scandium Exopolysaccharide Complexes on Several Cancer Cell Lines

Muñoz-Garcia J, Mazza M, Alliot C, Sinquin C, Colliec-Jouault S, Heymann D, Huclier-Markai S

Journal: Marine Drugs
Volume: 19, Issue 3
Année: Février 2021
Pages: Article 174

https://doi.org/10.3390/md19030174

Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy

Thureau S., Lebret L., Lequesne J., Cabourg M., Dandoy S., Gouley C., Lefebvre L., Mallet R., Mihailescu S.D., Moldovan C., Rigal O., Veresezan O., Modzewelski R., Clatot F.

Journal: Cancers
Volume: 13, Issue 4
Année: Février 2021
Pages: 753

https://doi.org/10.3390/cancers13040753

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III tr

Sébastien Thureau, Vincent Marchesi, Marie-Hélène Vieillard, Lionel Perrier, Albert Lisbona, Marianne Leheurteur, Jean Tredaniel, Stéphane Culine, Bernard Dubray, Naïma Bonnet, Bernard Asselain, Julia Salleron & Jean-Christophe Faivre

Journal: BMC Cancer
Volume: 21
Année: Février 2021
Pages: Article 117

https://doi.org/10.1186/s12885-021-07828-2

Variabilities in µQCT-based FEA of a tumoral bone mice model

Gardegaront M, Allard V, Confavreux C, Bermond F, Mitton D, Follet H.

Journal: Journal of Biomechanics
Volume: 118
Année: Mars 2021
Pages: 110265

https://doi.org/10.1016/j.jbiomech.2021.110265

Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program

Bertho M, Fraisse J, Patsouris A, Cottu P, Arnedos M, Pérol D, Jaffré A, Goncalves A, Lebitasy MP, D'Hondt V, Dalenc F, Ferrero JM, Levy C, Dabakuyo S, Rouzier R, Penault-Llorca F, Uwer L, Eymard JC, Breton M, Chevrot M, Thureau S, Petit T, Simon G, Frénel JS

Journal: Therapeutic Advances in Medical Oncology
Volume: 13
Année: Janvier 2021
Pages: Article 1758835920987657

https://doi.org/10.1177/1758835920987657

Development of prohibitin ligands against osteoporosis

Tabti R, Lamoureux F, Charrier C, Ory B, Heymann D, Bentouhami E, Désaubry L.

Journal: European Journal of Medicinal chemistry
Volume: 210
Année: Janvier 2021
Pages: 112961

https://doi.org/10.1016/j.ejmech.2020.112961

Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study

Vauléon E, Behal H, Lebellec L, Desbarbieux R, Baldacci S, Simon N, Pannier D, Vieillard MH, Turpin A.

Journal: Cancer Chemother Pharmacol
Volume: sous Presse
Année: Janvier 2021

https://doi.org/10.1007/s00280-020-04226-6

Bone Metastasis: Mechanisms, Therapies and Biomarkers

Clezardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, Confavreux CB, Holen I.

Journal: Physiological Reviews
Volume: Article Presse
Année: Janvier 2021

https://doi.org/10.1152/physrev.00012.2019